Month: November 2020

FDA Recalls Metformin After Finding Known Carcinogen

The FDA continues to recommend manufacturer recalls of the popular diabetes medication metformin after testing shows the presence of a known carcinogen, N-nitrosodimethylamine, more commonly known as NDMA. On October 5, 2020, the FDA alerted patients and health care professionals of two new metformin recalls for products manufactured by Marksans Pharma and Sun Pharmaceutical for …

FDA Recalls Metformin After Finding Known Carcinogen Read More »